ISPOR Health Science Initiatives

 

 

ISPOR HEALTH SCIENCE ACTION
March 2004 ISPOR Code of Ethics for Researchers published. Task Force
Chair: F. Palumbo Value in Health Vol. 7. No. 2 March/April 2004 http://www.ispor.org/workpaper/code_ethic.asp
August 2003 ISPOR Randomized Clinical Trial-Cost-effectiveness Task Force created.
Co-Chairs: S. Ramsey & R. Willke.
Task Force objectives and document outline: http://www.ispor.org/workpaper/clinical_trial.asp
July 2003 Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health Care Decision-making published.
Chair: M. Drummond
Value in Health Vol. 6. No. 4 July/August 2003 http://www.ispor.org/workpaper/healthscience/TFdecision2002.pdf
March 2003 A Checklist For Retrospective Database Studies - Report Of The ISPOR Task Force On Retrospective Databases published.
Chair: B. Motheral
Value in Health Vol. 6, No. 2 March/April 2003 http://www.ispor.org/workpaper/healthscience/ret_dbTFR0203.asp
January 2003 A Report of the ISPOR Health science Committee – Task Force on Good Research Practices – Modeling Studies published.
Chair: M. Weinstein
Value in Health Vol. 6, No. January/February 2003 http://www.ispor.org/workpaper/healthscience/TFModeling.pdf
April 2000 ISPOR Health Science Committee & Task Force members accept. (N. Otten, L. Morris, M. Weinstein, B. Motheral, P. Kind, M. Drummond, K. Matuszeski, F. Palumbo)
November 1999 Board of Directors approved the formation of the ISPOR Health Science Committee.
September 1999 Health Policy Strategy Ad Hoc Group Report issued recommending an ISPOR Health Science Committee, in addition to other recommendations.
June 1999 ISPOR Health Policy Strategy Ad Hoc Group formed. (A.Towse, K. Matuszewski, L. Morris, N. Otten)
November 1998 Final ISPOR Advisory Panel Meeting and Conference on Pharmacoeconomic Issues Report issued and published.
Value in Health Vol. 2, No. 2 March/April 1999 http://www.ispor.org/workpaper/adpanel/index_.asp
February 1998 ISPOR Advisory Panel Meeting and Conference on Pharmacoeconomic Issues.

 

For more information on ISPOR health science initiatives, see ISPOR Health Science Policy Council and the ISPOR Special Interest Group initiatives (http://www.ispor.org/sigs/sigsindex.asp)
 

 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.